Clinician compliance to recommendations regarding the risk of suicidality with selective serotonin reuptake inhibitors in the treatment of children and adolescents
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-165X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinician compliance to recommendations regarding the risk of suicidality with selective serotonin reuptake inhibitors in the treatment of children and adolescents ; day:7 ; month:11 ; year:2019 ; pages:1-12
European child & adolescent psychiatry ; (7.11.2019), 1-12
- Creator
-
Sørensen, Johanne Østerby
Rasmussen, Annette
Roesbjerg, Troels
Pagsberg, Anne Katrine
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00787-019-01435-0
- URN
-
urn:nbn:de:101:1-2020030419573208799097
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sørensen, Johanne Østerby
- Rasmussen, Annette
- Roesbjerg, Troels
- Pagsberg, Anne Katrine
- SpringerLink (Online service)
Other Objects (12)
Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Prenatal exposure to serotonin reuptake inhibitors: a case report
Veränderungen der Serotoninkinetik am Serotonin-Reuptake-Transporter (SERT) bei Reizdarmpatienten
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
The role of the serotonin reuptake transporter gene SLC6A4 and serotonin type 3 receptor variants in irritable bowel syndrome
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
Methylation of the serotonin reuptake transporter gene and non-motor symptoms in dystonia patients
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Prenatal exposure to serotonin reuptake inhibitors: a case report
Veränderungen der Serotoninkinetik am Serotonin-Reuptake-Transporter (SERT) bei Reizdarmpatienten
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
The role of the serotonin reuptake transporter gene SLC6A4 and serotonin type 3 receptor variants in irritable bowel syndrome
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
Methylation of the serotonin reuptake transporter gene and non-motor symptoms in dystonia patients
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Prenatal exposure to serotonin reuptake inhibitors: a case report
Veränderungen der Serotoninkinetik am Serotonin-Reuptake-Transporter (SERT) bei Reizdarmpatienten
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
The role of the serotonin reuptake transporter gene SLC6A4 and serotonin type 3 receptor variants in irritable bowel syndrome
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
Methylation of the serotonin reuptake transporter gene and non-motor symptoms in dystonia patients